Module16: Modified Seldinger Peritoneal Dialysis Catheter Placement
Module 16: Modified Seldinger Peritoneal Dialysis Catheter Placement
“This activity is jointly provided by Global Education Group and Kidney Academy.”
Target Audience The educational design of this activity addresses the needs of physicians and adjunct health care professionals (e.g., nurses, technologists) who treat kidney disease. Medical specialties addressed are relevant to transplant surgeons, radiologists, nephrologists, and vascular surgeons.
Statement of Need/Program Overview End stage renal disease (ESRD), specifically dialysis access, is a complicated condition treated by a variety of medical specialists with varied perspectives and skillsets. Population growth predictions suggest that the burden of providing maintenance dialysis in coming decades will be daunting. Access to reliable and applicable training in ESRD / dialysis access is limited, and significant treatment protocol disparity exists globally among professionals. The specialties performing dialysis access are fragmented into siloed societies with limited opportunity to understand the viewpoints of the other specialties serving the same patient.
After completing this activity, the participant should be better able to:
- Outline the principal features of the Percutaneous Modified Seldinger (PSPD) technique used for placement of Peritoneal Catheter (PD)
- Describe two key features that distinguishes this new approach from traditional Seldinger technique
- List the advantages of PSPD over other PD catheter insertion options
- Explain the use of PSPD in urgent need for dialysis
- Explain the ‘expanded’ indications for dialysis with the MSPD technique
- Discuss the risks of the PSPD technique and how to avoid complications
- Identify patient factors where PSPD is contraindicated
- Describe the value of Ultrasound in percutaneous PD catheter placement (also known as modified Seldinger PD catheter placement technique).
Jan Swinnen, MD Vascular Surgeon / Dialysis Access Specialist at Westmead Hospital in Sydney, Australia. He is a qualified Sonographer (DDU Vascular) and runs the Westmead Vascular Ultrasound Lab. He is Professor of Surgery at Sydney University and has an interest in clinical research.
Luke Baker, MD Interventional Radiologist and Dialysis Access Specialist at Westmead Hospital in Sydney, Australia. He is Professor at Sydney University and has an interest in clinical research.
Ingemar Davidson, MD, PhD, FACS Dr. Davidson is the founder of Kidney Academy, and focusing on organ procurement, organ transplantation, and dialysis access in ESKD patients, with published educational books and manuscripts on these topics.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Kidney Academy. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Term of Offering
This activity was released on 9.6.2021 and is valid for one year. Requests for credit must be made no later than 9.6.2022.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Instructions to Receive Credit
To receive credit for this activity, the participant must complete all sections and pass the post-test with at least 70% (11/15) questions answered correctly. The certificate will be available to download or print upon successful completion of the course material.
Fee Information & Refund/Cancellation Policy
There is no fee at this time for Module 16
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship
Jan Swinnen Nothing to Disclose
Ingemar Davidson Nothing to Disclose
Luke Baker Nothing to Disclose
The planners and managers have the following relevant financial relationships with ineligible companies:
NAME OF PLANNER OR MANAGER REPORT OF FINANCIAL RELATIONSHIP
Linda Borvabsky Nothing to Report
Andrea Funk Nothing to Report
Libby Knight Nothing to Report
Ashley Cam Nothing to Report
Therese Wykoff Nothing to Report
Tom Davis Nothing to Report
Steve White Nothing to Report
Erichson White Nothing to Report
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Kidney Academy do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
|Access Date||Quiz Result||Score||Actions|